Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Behçet Disease News

News
South Korea Reports Unprecedented Decline in Behçet Disease in Recent Years
12/20/2021
A recent study has showed that between 2004 and 2017, the incidence of Behçet disease decreased 81.5% in South Korea.
A recent study has showed that between 2004 and 2017, the incidence of Behçet disease decreased 81.5% in South Korea.
A recent study has showed that...
12/20/2021
Autoimmune
News
Potential for Severe COVID-19 Outcomes Among Patients With Vasculitis
12/05/2021
According to a recent study, risk factors associated with systemic vasculitis or polymyalgia rheumatica could lead to poor COVID-19 outcomes.
According to a recent study, risk factors associated with systemic vasculitis or polymyalgia rheumatica could lead to poor COVID-19 outcomes.
According to a recent study,...
12/05/2021
Autoimmune
News
Researchers Analyze Ocular Manifestations of Behcet Disease
11/01/2021
The prevalence of uveitis was examined for statistical difference among pediatric and adult patients and geographical region.
The prevalence of uveitis was examined for statistical difference among pediatric and adult patients and geographical region.
The prevalence of uveitis was...
11/01/2021
Autoimmune

Advertisement

News
Behçet Disease Shows Higher Prevalence Among Women in the US
09/20/2021
Male patients predominate in areas where Behçet disease is endemic, researchers note, but the ratio is reversed in the US.
Male patients predominate in areas where Behçet disease is endemic, researchers note, but the ratio is reversed in the US.
Male patients predominate in...
09/20/2021
Autoimmune
News
Multidisciplinary Team Describes Case of Vascular Behçet Syndrome
08/25/2021
Case study illustrates risk of aneurysm among patients with Behçet disease.
Case study illustrates risk of aneurysm among patients with Behçet disease.
Case study illustrates risk of...
08/25/2021
Autoimmune
Feature
Evolving Treatment for Patients With BD
06/29/2021
Researchers suggest patients with Behçet disease receive careful attention to disease activity, and may require treatment adjustments.
Researchers suggest patients with Behçet disease receive careful attention to disease activity, and may require treatment adjustments.
Researchers suggest patients...
06/29/2021
Autoimmune

Advertisement

News
Risk of Behçet’s Disease Heightened in First-Degree Relatives
06/29/2021
Studies show same-generation risks are highest.
Studies show same-generation risks are highest.
Studies show same-generation...
06/29/2021
Autoimmune
Research
Vascular Involvement in Behçet Disease
06/02/2021
Research reveals that vascular involvement was among top causes of hospitalization among patients with Behçet disease.
Research reveals that vascular involvement was among top causes of hospitalization among patients with Behçet disease.
Research reveals that vascular...
06/02/2021
Autoimmune
Feature
Determining Disease Severity in Patients With BD
05/11/2021
Inflammatory markers can be useful in determining disease severity among patients with Behçet disease, researchers revealed.
Inflammatory markers can be useful in determining disease severity among patients with Behçet disease, researchers revealed.
Inflammatory markers can be...
05/11/2021
Autoimmune

Advertisement

News
Ocular Inflammation Linked to Poor Outcomes Among Men With Behçet Disease
05/07/2021
Panuveitis, a common and frequent symptom of Behçet disease, is associated with poor visual prognosis, particularly among male patients.
Panuveitis, a common and frequent symptom of Behçet disease, is associated with poor visual prognosis, particularly among male patients.
Panuveitis, a common and...
05/07/2021
Autoimmune

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

Alan Bonder
Q&As
Alan Bonder, MD, on Extrahepatic Autoimmune Diseases in Patients With Primary Biliary Cholangitis
10/21/2020
About 25% of patients with one autoimmune disease are likely to develop another autoimmune condition. Dr Bonder, from Beth Israel Deaconess Medical Center in Boston, talks about the importance of screening patients with primary biliary...
About 25% of patients with one autoimmune disease are likely to develop another autoimmune condition. Dr Bonder, from Beth Israel Deaconess Medical Center in Boston, talks about the importance of screening patients with primary biliary...
About 25% of patients with one...
10/21/2020
Gastroenterology
News
Still Disease, Anxiety, and Depression: What’s the Connection?
12/25/2020
The researchers investigated mood status and health-related quality of life among patients with adult-onset Still disease. Here is what they found.
The researchers investigated mood status and health-related quality of life among patients with adult-onset Still disease. Here is what they found.
The researchers investigated...
12/25/2020
Autoimmune
News
Smoking and Psoriasis Risk: What Is the Connection?
10/30/2020
Researchers examined the impact of cigarette smoking on the prevalence and incidence of psoriasis and psoriatic arthritis. Here is what they found.
Researchers examined the impact of cigarette smoking on the prevalence and incidence of psoriasis and psoriatic arthritis. Here is what they found.
Researchers examined the impact...
10/30/2020
Autoimmune
Pop Quiz
Pop Quiz: Ankylosing Spondylitis and IBD
09/16/2020
Do you know whether ankylosing spondylitis affects patients with Crohn disease more often than those with ulcerative colitis, or vice versa? Find out by taking our pop quiz!
Do you know whether ankylosing spondylitis affects patients with Crohn disease more often than those with ulcerative colitis, or vice versa? Find out by taking our pop quiz!
Do you know whether ankylosing...
09/16/2020
Autoimmune
News
TNF-α Inhibitor Antibodies Negatively Affect Course of Inflammatory Joint Disease
07/31/2020
The presence of drug-induced neutralizing antibodies against tumor necrosis factor-α inhibitors may be a reliable biomarker for assessing treatment efficacy in patients with inflammatory joint diseases, a recent study shows.
The presence of drug-induced neutralizing antibodies against tumor necrosis factor-α inhibitors may be a reliable biomarker for assessing treatment efficacy in patients with inflammatory joint diseases, a recent study shows.
The presence of drug-induced...
07/31/2020
Autoimmune

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Stay In the Know

Autoimmune Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use